I research early (micro cap) and mid phase publicly traded companies in the Biotechnology and Medical Device sectors that are harder to at times find information on for investors. I believe that these companies, although potentially more volatile than their larger cap retail counterparts, hold great value. With a clear understanding of where their product is positioned in the market, the capitalization and the team, these smaller companies can hold incredible value over the long term. I have a varied background in both business and in the technical sector. Currently, I also am a co founder of BCN Biosciences in Pasadena CA, a privately held biotechnology company in addition to holding a research faculty position at the University of California Los Angeles Department of Radiation Oncology.
do my own private investing, through due dilligence..I was introduced to the CEO of Polymedix, He showed me a visual presentation of Brilaciden on his laptop. I was impressed . The R & D costs are overwhelming. CTIX now owns all the necessary data of Polymedix to continue the R & D. I believe CTIX would be a good fit for Cubist,who have similar interests in these types of antibiotics
I'm a value investor focused on buying companies trading below the intrinsic value.
I've a back ground in engineering & finance. I'm also a Chartered Financial Analyst. I did my MBA from Emory University's Goizueta School of Business
Lifetime investor with an affection for socially responsible investing, high-tech, biotech, REIT's and the occasional option play. Areas of expertise include law, energy efficiency technology, and writing. Divergences include Sword and Sorcery (novels and movies), international travel, and watching far too much television. Currently focusing on the short side of the market in anticipation of the next "Big Short" opportunity when $20T worth of debt finally sinks both the dollar and the Treasury Market.